G Medical Innovations Holdings Ltd (GMVDF)
OTCMKTS: GMVDF · Delayed Price · USD
0.0150
0.00 (0.00%)
Mar 27, 2024, 12:00 AM EDT - Market open

GMVDF Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Revenue
4.424.964.95.53
Revenue Growth (YoY)
-10.91%1.24%-11.33%-
Cost of Revenue
3.643.454.235.75
Gross Profit
0.781.510.67-0.22
Selling, General & Admin
20.6110.811.6510
Research & Development
2.291.681.322.55
Operating Expenses
22.912.4812.9712.56
Operating Income
-22.11-10.97-12.3-12.78
Interest Expense / Income
9.384.490.753.59
Other Expense / Income
-45.03-29.91-25.57-30.52
Pretax Income
13.5414.4512.5214.16
Income Tax
0.02-0-0.02-0.86
Net Income
13.5214.4612.5415.01
Net Income Growth
-6.47%15.32%-16.50%-
Shares Outstanding (Basic)
1004
Shares Outstanding (Diluted)
1004
Shares Change
122.18%54.45%-95.12%-
EPS (Basic)
-34.17-45.49-59.67-3.49
EPS (Diluted)
-34.17-45.49-59.67-3.49
Free Cash Flow
-20.57-11.98-5.15-6.73
Free Cash Flow Per Share
-28.53-36.92-24.54-1.56
Gross Margin
17.74%30.42%13.61%-4.04%
Operating Margin
-500.29%-221.08%-251.02%-231.25%
Profit Margin
305.90%291.41%255.84%271.68%
Free Cash Flow Margin
-465.32%-241.44%-105.18%-121.72%
Effective Tax Rate
0.12%-0.02%-0.14%-6.05%
EBITDA
24.1220.3114.6920.61
EBITDA Margin
545.79%409.35%299.71%373.02%
Depreciation & Amortization
1.211.361.422.87
EBIT
22.9118.9513.2717.74
EBIT Margin
518.37%381.90%270.78%321.08%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).